Clinical trial Recruiting at 3 sites Interventional Ages 2 and up

Active Fundament — building better motor skills and activity for preschoolers

Official title: An Active Fundament, Fundamentally Better: From an Early Age, Moving Well and Moving Enough as the Basis for a Lifetime of Physical Activity.

Run by Fontys University of Applied Sciences · NCT07315009 · Data updated 2026-11-12

This project will try a program in childcare centers to help 2–6-year-olds and their educators increase children's physical activity and basic motor skills.

Quick facts

Study typeInterventional
Ages2 Years and up
SexAll
Enrollment1000 (estimated)
SponsorFontys University of Applied Sciences
Academic / other
Locations3 sites (Maastricht, Limburg and 2 other locations)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedAugust 31, 2027
Study endsDecember 31, 2027
Registry record updatedJanuary 2, 2026
Trial IDNCT07315009 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are children aged 2–6 years who attend one of the participating child centers and the pedagogical staff and managers who work there.

Probably not a fit

Children who do not attend participating centers, children outside the 2–6 age range, or centers that do not fully implement the program may not receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This longitudinal, quasi-experimental program tests a training and support intervention delivered to pedagogical staff in 18 child centers (9 intervention, 9 control) to increase physical activity and fundamental motor skills in children aged 2–6 years. The approach combines on-site educator support, practical activity integration during the workday, and changes to the early childhood education and care environment. Children and staff are followed over time to measure changes in children's motor skill development and daily activity levels. The project also aims to produce a scalable package that other centers can adopt after the study.

Why it matters

Potential benefit: If successful, the program could help preschool children develop stronger motor skills, be more active daily, and give educators practical tools to make activity part of the day.

How similar studies have gone: Previous early-childhood education interventions have shown modest improvements in young children's physical activity and motor skills, so this approach builds on supportive but variable evidence and targets improved scalability.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children must be in the child center in the recruitment period(s)
* Professionals in ECEC and management must be working at the child center during the recruitment period.

Where it's running

  • Maastricht University
    Maastricht, Limburg, Netherlands
    Recruiting
  • Fontys Sport en Bewegen
    Eindhoven, North Brabant, Netherlands
    Recruiting
  • Hogeschool van Amsterdam
    Amsterdam, North Holland, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Adalimumab in Children with Crohn’s Disease (Pediatric 6–17)

    This study tests Taibowei Adalimumab injections in children aged 6 to 17 who have moderately to severely active Crohn’s disease to see how safe it is over 12, 26, and 52 weeks.

    Recruiting Phase 4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Guangzhou, Guangdong · NCT07564505

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.